HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that Colorado Springs, Colo., health systems, Memorial Health System and Penrose-St. Francis Health Services, are expanding facilities and services in the northeastern portion of the city, where there is a better-insured population. According to the new Colorado Springs Market Overview, these moves should provide economic growth that will offset higher rates of uncompensated care from the systems' centrally located flagship hospitals. With a shortage of acute-care bed space in the Colorado Springs market and above-average occupancy rates, the expansion efforts should pay dividends for each health system.

Penrose-St. Francis Health Services opened St. Francis Medical Center in August 2008, as a replacement to Penrose Community Hospital. Penrose Community Hospital will function as an urgent-care facility until the hospital is sold, though the system plans to open a permanent urgent-care facility in the central portion of the city. Urgent-care facilities are in demand, particularly as there is currently a local physician shortage.

City-owned Memorial Health System began its expansion in 2007, including the opening of Memorial Hospital North in the northeastern corner of Colorado Springs. In addition to the new hospital, the system's growth plan also includes attracting physicians to its 123,000-square-foot medical office tower near Memorial North, which is nearly full.

"Both Penrose-St. Francis Health Services and Memorial Health System are hoping that by providing services to better-insured patients in the northern region of the city, they can offset the losses seen from their flagship locations," said Dave Raiford, market analyst with HealthLeaders-InterStudy and the report's author. "Penrose-St. Francis seems to be taking a measured approach with the opening of a replacement facility that puts less risk on the health system. Memorial's move is one of necessity as it is responsible for a majority of the uncompensated care in the Colorado Springs metropolitan statistical area, and carries a heavier Medicaid load than Penrose-St. Francis."

About Market Overviews

Market Overviews provide a detailed analysis of local healthcare markets, allowing healthcare businesses to plan their local strategies. In addition to the 75 metropolitan statistical areas covered in our individual market reports, HealthLeaders-InterStudy will be producing the following NEW Market Overview reports in 2008:

  Baton Rouge, La.   Cape Coral/Fort Myers, Fla.   Charleston, S.C.   Colorado Springs, Colo.   Columbia, S.C.   Lexington, Ky.   Madison, Wis.   Portland, Maine   Southern New Jersey   Spokane, Wash.   Springfield, Mass.   Wilmington, Del.     About HealthLeaders-InterStudy 

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit http://www.healthleaders-interstudy.com/.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com/.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Lisa Osgood                        Elizabeth Marshall   HealthLeaders-InterStudy           Decision Resources, Inc.   781-296-2606                       781-296-2563   losgood@hl-isy.com                 emarshall@dresources.com 

First Call Analyst:
FCMN Contact:

SOURCE: HealthLeaders-InterStudy

Contact: Lisa Osgood of HealthLeaders-InterStudy, +1-781-296-2606,
losgood@hl-isy.com; or Elizabeth Marshall of Decision Resources, Inc.,
+1-781-296-2563, emarshall@dresources.com

Robust Sales of Integrilin, ReoPro and Aggrastat Will Drive the Unstable Angina/Non-ST-Elevation Myocardial Infarction Drug Market

View Now